Related references
Note: Only part of the references are listed.CD200 expression in plasma cell myeloma
Horatiu Olteanu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell-Derived Neoplasms
David M. Dorfman et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Hematogones: a review and update
Deborah W. Sevilla et al.
LEUKEMIA & LYMPHOMA (2010)
Characterization of Immunophenotypic Aberrancies in 200 Cases of B Acute Lymphoblastic Leukemia
Adam C. Seegmiller et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Small B-Cell Neoplasms With Typical Mantle Cell Lymphoma Immunophenotypes Often Include Chronic Lymphocytic Leukemias
Albert K. Ho et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Immunophenotypic Variations in Mantle Cell Lymphoma
Juehua Gao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
The molecular characterization and clinical management of multiple myeloma in the post-genome era
Y. Zhou et al.
LEUKEMIA (2009)
CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia
Giuseppe A. Palumbo et al.
LEUKEMIA RESEARCH (2009)
Flow cytometric immunophenotyping for hematologic neoplasms
Fiona E. Craig et al.
BLOOD (2008)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
CD200 as a prognostic factor in acute myeloid leukaemia
A. Tonks et al.
LEUKEMIA (2007)
CD200 is a new prognostic factor in multiple myeloma
Jerome Moreaux et al.
BLOOD (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
Ichiro Hanamura et al.
BLOOD (2006)
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
DR Carrasco et al.
CANCER CELL (2006)
Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation
JR McWhirter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of myeloid cell function through the CD200 receptor
MC Jenmalm et al.
JOURNAL OF IMMUNOLOGY (2006)
Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200
I Shiratori et al.
JOURNAL OF IMMUNOLOGY (2005)
Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry
RW McKenna et al.
LEUKEMIA & LYMPHOMA (2004)
Characterization of the CD200 receptor family in mice and humans and their interactions with CD200
GJ Wright et al.
JOURNAL OF IMMUNOLOGY (2003)
CD200 and membrane protein E interactions in the control of myeloid cells
AN Barclay et al.
TRENDS IN IMMUNOLOGY (2002)
Novel evidence of a role for chromosome I pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma
P Le Baccon et al.
GENES CHROMOSOMES & CANCER (2001)
Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density
G D'Arena et al.
LEUKEMIA & LYMPHOMA (2001)
Down-regulation of the macrophage lineage through interaction with OX2 (CD200)
RM Hoek et al.
SCIENCE (2000)
Share Paper
